Clinical trial
Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living…
NCT00223067 · University Hospital Schleswig-Holstein, Other · Unknown status
Key facts
| NCT number | NCT00223067 |
|---|---|
| Title | Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes |
| Official title | A Multi-Center Open-Labeled Study of the Administration of Allogenic and Autologous Regulatory Cells for the Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) |
| Lead sponsor | University Hospital Schleswig-Holstein, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | TAIZ |
| Enrollment | 10 |
| Start date | Mar 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 28, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: